Search results
What to Know About Jean Smart's Health
Parade via AOL· 6 days agoHacks paused filming temporarily for Season 3 to allot time for Smart's recovery. Is Jean Smart diabetic? Smart has Type 1 diabetes, ...
What is behind the insulin shortage in the US?
Al Jazeera· 7 days agoSkye Murphy, who is 22 years old, has lived with type 1 diabetes since she was 14. In the past month, she learned that there would be ...
Lexicon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
Morningstar· 7 days agoCommercial launch of INPEFA® (sotagliflozin) for Heart Failure continues to progress Resubmission of NDA for ZYNQUISTA™ (sotagliflozin) in Type 1
What are the real benefits of intermittent fasting?
The Telegraph via Yahoo News· 6 days agoIt’s not just the fat-burning benefits that make intermittent fasting so popular. Hailed for boosting our “metabolic resilience”, studies show that...
Losing weight with intermittent fasting: What to know
FOX 8 Cleveland· 2 days agoIntermittent fasting is one of the fastest growing diet trends around the world and in the United...
Lexicon Pharmaceuticals Reports Q1 2024 Earnings: Aligns with EPS Projections Amidst Strategic ...
GuruFocus.com via Yahoo Finance· 6 days agoStrategic Developments: Advancing towards a mid-year NDA resubmission for ZYNQUISTA in type 1 ...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 2 days agoThe study is being conducted by the research team at University of Chicago Medicine’s Pancreatic and Islet Transplant Program.
Diabetes/Weight Loss Med Linked to Repeat Spinal Surgery
Medscape· 1 day agoThe diabetes/weight loss drug semaglutide is associated with a significantly greater risk for repeat...
Adding AI to artificial pancreas enhances efficiency, study finds
Medical Xpress· 7 days agoIn the study, UVA researchers compared an advanced experimental artificial pancreas system—which...
Analyst Report: CRISPR Therapeutics AG
Morningstar Research via Yahoo Finance· 9 hours agoThe company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals ...
